Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
3.490
+0.080 (2.35%)
At close: Dec 20, 2024, 4:00 PM
3.500
+0.010 (0.29%)
After-hours: Dec 20, 2024, 6:38 PM EST
Xeris Biopharma Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | -63.11 | -62.26 | -94.66 | -122.73 | -91.14 | -125.58 | Upgrade
|
| Depreciation & Amortization | 12.75 | 13.16 | 12.67 | 1.88 | 1.47 | 1.08 | Upgrade
|
| Other Amortization | 2.71 | 2.21 | 1.56 | 0.96 | 0.98 | 0.95 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.32 | 0.32 | 0.24 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.82 | -1.26 | 0.18 | 0.41 | 0.08 | -0.69 | Upgrade
|
| Stock-Based Compensation | 17.54 | 10.72 | 12.16 | 11.38 | 8.27 | 6.48 | Upgrade
|
| Other Operating Activities | -10.03 | -3.61 | 0.11 | 0.7 | 2.58 | 1.63 | Upgrade
|
| Change in Accounts Receivable | 4.83 | -8.37 | -13.37 | -6.24 | -2.18 | -4.69 | Upgrade
|
| Change in Inventory | -7.05 | -14.8 | -7.47 | -7.42 | -5.14 | -2.18 | Upgrade
|
| Change in Accounts Payable | -4.76 | 6.96 | -4.32 | 5.53 | -2.49 | 4.74 | Upgrade
|
| Change in Other Net Operating Assets | 16.15 | 9.92 | -9.99 | 19.98 | 7.01 | 13.91 | Upgrade
|
| Operating Cash Flow | -31.49 | -47.02 | -102.89 | -95.54 | -80.56 | -104.35 | Upgrade
|
| Capital Expenditures | -0.78 | -2.26 | -0.52 | -1.09 | -0.38 | -1.11 | Upgrade
|
| Cash Acquisitions | - | - | - | 38.47 | - | - | Upgrade
|
| Investment in Securities | 10.52 | -3.74 | 34.99 | 60.58 | -27.03 | -1.28 | Upgrade
|
| Investing Cash Flow | 9.74 | -6 | 34.46 | 97.96 | -27.41 | -2.38 | Upgrade
|
| Long-Term Debt Issued | - | - | 146.21 | - | 94.84 | 60 | Upgrade
|
| Long-Term Debt Repaid | - | - | -43.5 | - | -25.09 | -35 | Upgrade
|
| Net Debt Issued (Repaid) | 50 | - | 102.72 | - | 69.75 | 25 | Upgrade
|
| Issuance of Common Stock | 1.17 | 0.58 | 30.84 | 27.84 | 66.7 | 62.38 | Upgrade
|
| Repurchase of Common Stock | -3.62 | -1.01 | -0.47 | -0.53 | -0.06 | - | Upgrade
|
| Other Financing Activities | -13.02 | -1.19 | -5.61 | -0.05 | -10.32 | -6.85 | Upgrade
|
| Financing Cash Flow | 34.54 | -1.61 | 127.47 | 27.25 | 126.06 | 80.53 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | -0 | -0.02 | 0 | Upgrade
|
| Net Cash Flow | 12.79 | -54.64 | 59.04 | 29.67 | 18.08 | -26.2 | Upgrade
|
| Free Cash Flow | -32.27 | -49.29 | -103.42 | -96.62 | -80.94 | -105.45 | Upgrade
|
| Free Cash Flow Margin | -17.22% | -30.07% | -93.80% | -194.84% | -396.06% | -3874.10% | Upgrade
|
| Free Cash Flow Per Share | -0.22 | -0.36 | -0.76 | -1.22 | -1.90 | -4.04 | Upgrade
|
| Cash Interest Paid | 26.55 | 27.69 | 10.86 | 7.29 | 4.56 | 3.72 | Upgrade
|
| Levered Free Cash Flow | -30.72 | -19.62 | -64.92 | -28.19 | -52.91 | -63.06 | Upgrade
|
| Unlevered Free Cash Flow | -14.8 | -5.2 | -57.67 | -24.67 | -47.22 | -59.53 | Upgrade
|
| Change in Net Working Capital | 16.08 | -0.7 | 31.69 | -29.09 | 5.62 | -10.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.